News Center

• Sep. 30

  2024

  VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH JIANGSU ALPHAMAB FOR THE DEVELOPMENT AND COMMERCIALIZATION OF JSKN003 IN MAINLAND CHINA

• Sep. 20

  2024

  VOLUNTARY ANNOUNCEMENT - VALSARTAN LEVOAMLODIPINE MALEATE TABLETS OBTAINS CLINICAL TRIAL APPROVAL

• Sep. 16

  2024

  VOLUNTARY ANNOUNCEMENT AMPHOTERICIN B LIPOSOME FOR INJECTION OBTAINS DRUG REGISTRATION APPROVAL

• Sep. 10

  2024

  VOLUNTARY ANNOUNCEMENT APREPITANT INJECTION OBTAINS DRUG REGISTRATION APPROVAL

• Aug. 29

  2024

  VOLUNTARY ANNOUNCEMENT DEXRAZOXANE FOR INJECTION OBTAINS DRUG REGISTRATION APPROVAL

• Aug. 09

  2024

  2024 China Pharmaceutical Brand Value list: CSPC Pharma ranked sixth